Action BG Medicine (CE) - BGMD

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,000001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,00013

Clôture Veille

0,000001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

37 188

Volume financier

VWAP

Automated Galectin-3 Blood Test Launch - Report on BG Medicine

Automated Galectin-3 Blood Test Launch - Report on BG Medicine PR Newswire NEW YORK, July 21, 2015 NEW YORK, July 21, 2015 /PRNewswire/ -- ACI...

BG Medicine Reports First Quarter 2015 Financial Results

Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014 Outlook Improved for...

BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the...

BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test

WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM...

BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results

Net Loss Reduced by 49% and Operating Cash Burn Cut by 47% From 2013 First Automated Galectin-3 Testing...

BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the...

BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., March 24, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the...

BG Medicine Announces Receipt of NASDAQ Notice of Non-Compliance; Intends to Request Hearing and Seek Extension

WALTHAM, Mass., March 13, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) (the "Company"), the...

BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination

WALTHAM, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM...

BG Medicine Reports First Quarter 2014 Financial Results

Net Loss Reduced by 60% and Operating Cash Burn Cut by 44% From First Quarter 2013 Continued Progress...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	275	1.0E-6	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	37188	1.0E-6	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	21637	1.0E-6	CS
52	0	0	1.0E-6	0.00013	1.0E-6	14665	1.06E-6	CS
156	0	0	1.0E-6	0.02	1.0E-6	10961	0.00014431	CS
260	-0.020999	-99.9952380952	0.021	0.257	1.0E-6	16870	0.04855442	CS

BGMD - Frequently Asked Questions (FAQ)

What is the current BG Medicine (CE) share price?

The current share price of BG Medicine (CE) is US$ 0,000001

What is the 1 year trading range for BG Medicine (CE) share price?

BG Medicine (CE) has traded in the range of US$ 0,000001 to US$ 0,00013 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,02 (1 999 900,00%)	278
NLVVFNew Leaf Ventures (CE)	US$ 0,0089 (889 900,00%)	6,92k
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0,008 (799 900,00%)	101
ETBIEastgate Biotech Corporation (CE)	US$ 0,0045 (449 900,00%)	2k
VWESQVintage Wine Estates Inc (CE)	US$ 0,002 (199 900,00%)	3,44k
NEXINexImmune Inc (CE)	US$ 0,0001 (-99,90%)	13,59k
JERTQJER Investors Trust Inc New (CE)	US$ 0,000001 (-99,67%)	10k
AGILQAgileThought Inc (CE)	US$ 0,0001 (-99,10%)	4,7k
GAYGFMontauk Metals Inc (PK)	US$ 0,0012 (-99,08%)	6,25k
IONMAssure Holdings Corporation (CE)	US$ 0,000001 (-99,00%)	112
HMBLHUMBL Inc (PK)	US$ 0,0005 (25,00%)	279,83M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0026 (-3,70%)	123,47M
SPQSSportsQuest Inc (PK)	US$ 0,0001 (-50,00%)	114,57M
BOMObowmo Inc (PK)	US$ 0,0001 (0,00%)	102,85M
VTXBVortex Brands Company (PK)	US$ 0,0001 (0,00%)	101,18M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

BG Medicine Inc (CE) (BGMD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

BGMD Dernières nouvelles

Automated Galectin-3 Blood Test Launch - Report on BG Medicine

BG Medicine Reports First Quarter 2015 Financial Results

BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information

BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test

BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results

BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information

BG Medicine Announces Receipt of NASDAQ Notice of Non-Compliance; Intends to Request Hearing and Seek Extension

BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination

BG Medicine Reports First Quarter 2014 Financial Results

BGMD - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

BG Medicine Inc (CE) (BGMD) Cours

BG Medicine Inc (CE) (BGMD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

BGMD Dernières nouvelles

Automated Galectin-3 Blood Test Launch - Report on BG Medicine

BG Medicine Reports First Quarter 2015 Financial Results

BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information

BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test

BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results

BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information

BG Medicine Announces Receipt of NASDAQ Notice of Non-Compliance; Intends to Request Hearing and Seek Extension

BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination

BG Medicine Reports First Quarter 2014 Financial Results

BGMD - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités